Glossary of medical terms: A B C D E F G H I J K L M N O P Q R S T U W V Y Z
Home » Medical Dictionary
 

  Progressive Multifocal Leukoencephalopathy

Medical Dictionary

Definition of medical terminology for Progressive Multifocal Leukoencephalopathy.
An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES).
The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months.
(From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)

Search results Medical News for - Progressive Multifocal Leukoencephalopathy

» World-Renowned Yogi Baron Baptiste Unveils New Program to Help People with Multiple Sclerosis
» Large Body of Data on TYSABRI to Be Presented at Annual Meeting of the American Academy of Neurology
» FDA Drug Safety Communication: Safety update on Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
» FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)
» FDA approves Rituxan to treat two rare disorders
» European Commission Approves Inclusion of Anti-JC Virus Antibody Status as a PML Risk Factor in TYSABRI Labeling
» ELEASE DETAILS current archive inks Print Current | Archive Data Further Supporting Anti-JC Virus Antibody Assay Presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
» Data about Early Use and Long-Term Benefit of TYSABRI Presented at 5th Joint Triennial Congress of ECTRIMS and ACTRIMS
» CHMP Recommends Updating TYSABRI Labeling with anti-JC Virus Antibody Status as a Third Factor to Further Stratify Risk of PML

Latest Medical Articles

» Wrist Injuries and Disorders
» West Nile Virus
» Wegener`s Granulomatosis
» Vulvar Disorders
» Vulvar Cancer
» Vitiligo
» Von Hippel-Lindau Disease
 

Search results Leaflet Drugs for - Progressive Multifocal Leukoencephalopathy

» Tysabri
» Raptiva
» Ofatumumab (Intravenous Route)
» Natalizumab (Intravenous Route)
» Myfortic
» Mycophenolate Sodium (Oral Route)
» Mycophenolate (Intravenous Route)
» Efalizumab (Subcutaneous Route)
» Arzerra
 

Random terms - Medical Dictionary

Unconsciousness, temporary, AWOL, ACL, Abnormal, Dataphones, Diagnostic Technique, Otologic, DIC, Epidural Abscess, Spinal, Factor Analyses, gamma-2b-Immunoglobulin, ICI 46474, Infantile Cerebral Palsy, Diplegic, Isomeroreductase, 2-Acetohydroxy-3-Ketoacid, Keoflo, Laboratory Diagnosis, Lobes, Temporal, Lymphoma, Large-Cell Immunoblastic, Medically Underserved Area, Minor Histocompatibility Antigens, Motifs, Helix-Turn-Helix, Mumps Vaccine, Nalbuphine Hydrochloride, p-Chlorophenoxyisobutyric Acid, Pain Syndrome, Craniofacial, Partial Epilepsy, Sensory, Post-Cholecystectomy Syndrome, Procollagen Type VI, Pupils, Fixed, Behavior, Firesetting, Receptors, Glucocorticoid, Refractory Periods, Psychological, S 18506, Salt Estradiol, Monosodium, Satellite RNAs, Semilobar Holoprosencephaly, Social Characteristics, Squatters, Superior Vena Cava, Supplement, Food, Support, Spousal,

General Search


Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap